Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
allergan
3
×
biotech
clinical trials
europe blog main
3
×
fda
life sciences
national
3
×
national blog main
national top stories
new york blog main
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
crispr
detroit blog main
detroit top stories
eli lilly
europe top stories
indiana blog main
indiana top stories
ipo
merck
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
sanofi
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
acceleron pharma
What
bio
medicines
roundup
acquisitions
adults
allergan
announced
approved
black
ceo
class
collabs
companies
continue
covid
daniel
deal
debut
diamond
diamond’s
fda
gilead
gilead’s
help
indication
introduce
ipo
leading
life
mammoth
march
migraine
monday
month
moves
new
nod
ohana’s
o’day
pill
Language
unset
Current search:
allergan
×
national
×
" europe blog main "
×
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More
@xconomy.com
4 years ago
Allergan Wins FDA Nod for First Migraine Pill in New Class of Medicines